Bilaketaren emaitzak - Chester A. Mathis

Findu emaitzak
  1. 1
    The future of amyloid-beta imaging: a tale of radionuclides and tracer proliferation

    The future of amyloid-beta imaging: a tale of radionuclides and tracer proliferation nork William E. Klunk, Chester A. Mathis

    Argitaratua 2008
    Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  2. 2
    In vitro evaluation of [3H]PI-2620 and structural derivatives in non-Alzheimer's tauopathies

    In vitro evaluation of [3H]PI-2620 and structural derivatives in non-Alzheimer's tauopathies nork Cassis Varlow, Chester A. Mathis, Neil Vasdev

    Argitaratua 2024
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  3. 3
    Positron emission tomography radioligands for <i>in vivo</i> imaging of A<i>β</i> plaques

    Positron emission tomography radioligands for <i>in vivo</i> imaging of A<i>β</i> plaques nork N. Scott Mason, Chester A. Mathis, William E. Klunk

    Argitaratua 2013
    Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  4. 4
    Impact of amyloid imaging on drug development in Alzheimer's disease

    Impact of amyloid imaging on drug development in Alzheimer's disease nork Chester A. Mathis, Brian J. Lopresti, William E. Klunk

    Argitaratua 2007
    Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  5. 5
    Imaging Amyloid-β Deposits <i>In Vivo</i>

    Imaging Amyloid-β Deposits <i>In Vivo</i> nork Brian J. Bacskai, William E. Klunk, Chester A. Mathis, Bradley T. Hyman

    Argitaratua 2002
    Testu osoa Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  6. 6
    Development of Positron Emission Tomography β-Amyloid Plaque Imaging Agents

    Development of Positron Emission Tomography β-Amyloid Plaque Imaging Agents nork Chester A. Mathis, N. Scott Mason, Brian J. Lopresti, William E. Klunk

    Argitaratua 2012
    Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  7. 7
    Does my mouse have Alzheimer's disease?

    Does my mouse have Alzheimer's disease? nork Jean‐Cosme Dodart, Chester A. Mathis, Kelly R. Bales, Steven M. Paul

    Argitaratua 2002
    Testu osoa Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  8. 8
    Spatial patterns of brain amyloid- burden and atrophy rate associations in mild cognitive impairment

    Spatial patterns of brain amyloid- burden and atrophy rate associations in mild cognitive impairment nork Duygu Tosun, Norbert Schuff, Chester A. Mathis, William J. Jagust, Michael Weiner

    Argitaratua 2011
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  9. 9
    Small-molecule PET Tracers for Imaging Proteinopathies

    Small-molecule PET Tracers for Imaging Proteinopathies nork Chester A. Mathis, Brian J. Lopresti, Miloš D. Ikonomović, William E. Klunk

    Argitaratua 2017
    Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  10. 10
    Prefrontal and Striatal Dopamine Release Are Inversely Correlated in Schizophrenia

    Prefrontal and Striatal Dopamine Release Are Inversely Correlated in Schizophrenia nork W. Gordon Frankle, Michael L. Himes, N. Scott Mason, Chester A. Mathis, Rajesh Narendran

    Argitaratua 2022
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  11. 11
    Cortical cholinergic denervation is associated with depressive symptoms in Parkinson's disease and parkinsonian dementia

    Cortical cholinergic denervation is associated with depressive symptoms in Parkinson's disease and parkinsonian dementia nork Nicolaas I. Bohnen, Daniel Kaufer, Rick Hendrickson, Gregory Constantine, Chester A. Mathis, R.Y. Moore

    Argitaratua 2007
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  12. 12
    [F‐18]AV‐1451 positron emission tomography retention in choroid plexus: More than “off‐target” binding

    [F‐18]AV‐1451 positron emission tomography retention in choroid plexus: More than “off‐target” binding nork Miloš D. Ikonomović, Eric E. Abrahamson, Julie C. Price, Chester A. Mathis, William E. Klunk

    Argitaratua 2016
    Testu osoa
    Carta
    Gogokoenen artean sartu
    Gorde:
  13. 13
    Two-year follow-up of amyloid deposition in patients with Alzheimer's disease

    Two-year follow-up of amyloid deposition in patients with Alzheimer's disease nork William E. Klunk, Chester A. Mathis, Julie C. Price, Brian J. Lopresti, Steven T. DeKosky

    Argitaratua 2006
    Testu osoa Testu osoa
    Carta
    Gogokoenen artean sartu
    Gorde:
  14. 14
    Memory-enhancing effects of secreted forms of the β-amyloid precursor protein in normal and amnestic mice

    Memory-enhancing effects of secreted forms of the β-amyloid precursor protein in normal and amnestic mice nork Hamid Méziane, Jean‐Cosme Dodart, Chester A. Mathis, Sharon Little, James C. Clemens, Stéphane Paul, Arielle Ungerer

    Argitaratua 1998
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  15. 15
    Using Pittsburgh Compound B for In Vivo PET Imaging of Fibrillar Amyloid-Beta

    Using Pittsburgh Compound B for In Vivo PET Imaging of Fibrillar Amyloid-Beta nork Ann D. Cohen, Gil D. Rabinovici, Chester A. Mathis, William J. Jagust, William E. Klunk, Miloš D. Ikonomović

    Argitaratua 2012
    Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  16. 16
    Post-mortem analyses of PiB and flutemetamol in diffuse and cored amyloid-β plaques in Alzheimer’s disease

    Post-mortem analyses of PiB and flutemetamol in diffuse and cored amyloid-β plaques in Alzheimer’s disease nork Miloš D. Ikonomović, Christopher Buckley, Eric E. Abrahamson, Julia Kofler, Chester A. Mathis, William E. Klunk, Gill Farrar

    Argitaratua 2020
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  17. 17
    <i>In Silico</i> Discovery and Subsequent Characterization of Potent 4R-Tauopathy Positron Emission Tomography Radiotracers

    <i>In Silico</i> Discovery and Subsequent Characterization of Potent 4R-Tauopathy Positron Emission Tomography Radiotracers nork Thomas J. A. Graham, Anton Lindberg, Junchao Tong, Jeffrey S. Stehouwer, Neil Vasdev, Robert H. Mach, Chester A. Mathis

    Argitaratua 2023
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  18. 18
    Amyloid-β Imaging with Pittsburgh Compound B and Florbetapir: Comparing Radiotracers and Quantification Methods

    Amyloid-β Imaging with Pittsburgh Compound B and Florbetapir: Comparing Radiotracers and Quantification Methods nork Susan Landau, Christopher Breault, Abhinay D. Joshi, Michael J. Pontecorvo, Chester A. Mathis, William J. Jagust, Mark A. Mintun

    Argitaratua 2012
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  19. 19
    Amphetamine induced dopamine release increases anxiety in individuals recovered from anorexia nervosa

    Amphetamine induced dopamine release increases anxiety in individuals recovered from anorexia nervosa nork Ursula F. Bailer, Rajesh Narendran, W. Gordon Frankle, Michael L. Himes, Vikas Duvvuri, Chester A. Mathis, Walter H. Kaye

    Argitaratua 2011
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  20. 20
    Carbon 11–Labeled Pittsburgh Compound B and Carbon 11–Labeled (R)-PK11195 Positron Emission Tomographic Imaging in Alzheimer Disease

    Carbon 11–Labeled Pittsburgh Compound B and Carbon 11–Labeled (R)-PK11195 Positron Emission Tomographic Imaging in Alzheimer Disease nork Clayton A. Wiley, Brian J. Lopresti, Sriram Venneti, Julie Price, William E. Klunk, Steven T. DeKosky, Chester A. Mathis

    Argitaratua 2009
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:

Bilaketa egiteko lanabesak: